Immunocytochemistry for choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT) was used to examine the expression of these linked cholinergic markers in human basal forebrain, including cases with early stages of Alzheimer's disease (AD). Previous neurochemical studies
Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease
✍ Scribed by Mark A. Lovell; Jennifer L. Smith; Shuling Xiong; William R. Markesbery
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 376 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1029-8428
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background Chronic and heavy alcohol abuse or dependence may result in impaired cognition and dementia. The increased risk of Alzheimer's disease (AD) in older individuals interferes with the differential diagnosis, especially when dealing with elderly patients with a long history of alcohol abuse.
## Abstract Alzheimer's disease (AD) is the most common form of dementia and is pathologically characterized by senile plaques, neurofibrillary tangles, synaptic disruption and loss, and progressive neuronal deficits. The exact mechanism(s) of AD pathogenesis largely remain unknown. With advances i